Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medivation Inc    MDVN

 SummaryQuotesNewsCompany 
Company
Medivation, Inc. engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options.The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. 
More about the company
Latest news on MEDIVATION INC
2016 Drugmaker Sanofi hungry for deals after earnings beat
2016 MEDIVATION : New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼..
2016 PFIZER : Completes Acquisition of Medivation
2016 MEDIVATION, INC. : Termination of a Material Definitive Agreement, Completion of..
2016 PFIZER INC. (NYSE : PFE) Acquisition Of Medivation, Inc. (NASDAQ:MDVN) To Close ..
2016 Xenon Pharmaceuticals Appoints Dawn Svoronos to Its Board of Directors
2016 MEDIVATION : Highlights New Data From Differentiated Oncology Portfolio at ESMO ..
2016 PFIZER : Announces Expiration of HSR Waiting Period For Proposed Acquisition of ..
2016DJPfizer Throws Out Plan to Split Into Two Companies
2016 PFIZER : expects to close Medivation buyout in 3Q
More news
Sector news : Bio Therapeutic Drugs
05/23 UK competition watchdog accuses Merck of obstructing biosimilars
05/22 Cross-border M&A between U.S. and European firms at 10 year high
05/22DJAMGEN : Another Gloomy Day for Amgen
05/09 Sanofi pegs U.S. drug price rises to below healthcare inflation
05/09DJVERTEX PHARMACEUTICALS INCORPORATED : Trump's Pick to Lead FDA Has Backing of Bi..
More sector news : Bio Therapeutic Drugs
Latest Tweets
05/24Ahead of #ASCO17 our health care team hosted call on #breastcancer treatment .. 
05/22Former Medivation space grabbed by growing machine learning/#AI company WalkM..
1
05/22Former Medivation space grabbed by growing machine learning/#AI company WalkM.. 
05/18Pfizer drug from Medivation deal shows promise in breast cancer: study
3
05/18Pfizer drug from Medivation deal shows promise in breast cancer: study
3
More tweets
Qtime:38
News from SeekingAlpha
05/17 Vantage Point - Are Charities The Best Way To Pay For Costly Drugs?
04/10 Axovant Sciences announces appointment of Dr. David Hung as CEO and expansion..
03/06 BIOTECH FORUM DAILY DIGEST : Biotech Closes Above Resistance Levels. Icahn Getti..
02/10 BIOTECH FORUM DAILY DIGEST : Buyout Rumors On The Rise; Aratana Therapeutics' De..
02/03 Pfizer May Be Another IBM
Advertisement
Technical analysis trends MEDIVATION INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Managers
NameTitle
David T. Hung President, Chief Executive Officer & Director
Kim D. Blickenstaff Chairman
Jennifer Jarrett Chief Financial Officer
Mohammad Hirmand Chief Medical Officer
Anne Bowdidge Senior Director-Investor Relations
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MEDIVATION INC0.00%0
AMGEN, INC.6.02%113 994
CELGENE CORPORATION0.89%91 185
GILEAD SCIENCES, INC.-9.93%84 284
REGENERON PHARMACEUTIC..23.99%48 380
ACTELION LTD24.38%30 602
More Results